Laszlo Radvanyi

Laszlo Radvanyi, a renowned professor of immunology and cancer immunotherapy, discusses pivotal advancements in cancer treatments. He reflects on the evolution of immunotherapy over the last decade and shares insights on the challenges of activating immune pathways with agonist antibodies. Laszlo emphasizes the role of partnerships in translating basic research into clinical success and highlights the promising potential of early detection strategies. He also argues for the exploration of new antigen sources, including endogenous retroviruses, as future targets in cancer therapy.